HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.

60 Clinical Trials
Lymphoma NA Accepting Patients
nct/study# NA / EURPT00000067-PT-SK

Single Patient Emergency Use IND Of PLX-PAD In Patient GDB

Learn More
Lymphoma Phase III Accepting Patients
nct/study# NCT01804686 / PCI32765CAN3001-EXT

A Phase 3b, Multicenter, Open-Label, PCI-32765 (Ibrutinib) Long-Term Extension Study

Learn More
Lymphoma Phase II Accepting Patients
nct/study# NCT02601313 / KTE-C19-102

A Phase 2 Multicenter Study Evaluating The Efficacy Of KTE-C19 In Subjects With Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)

Learn More
Lymphoma NA Accepting Patients
nct/study# NCT03229200 / PCYC-1145-LT

Extended Treatment Protocol For Subjects Continuing To Benefit From Ibrutinib After Completion Of Ibrutinib Clinical Trials

Learn More
Lymphoma NA Accepting Patients
nct/study# NA / 2020-0342-RWD-COVID

Real World Observational Database For COVID-19 Treatment And Outcomes

Learn More
Lymphoma NA Accepting Patients
nct/study# NA / 2021-0512

Clinical Efficacy And Mechanisms Of Resistance To Polatuzumab Vedotin In Patients With Large B-Cell Lymphoma After CAR T-Cell Therapy

Learn More

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.